UNITED THERAPEUTICS Corp
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
| UNITED THERAPEUTICS CORPORATION | ||
| By: | /s/ MARTINE ROTHBLATT | |
| February 25, 2026 | Martine Rothblatt, Ph.D.Chairperson and Chief Executive Officer |
|---|
| 73 | United Therapeutics, a public benefit corporation |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signatures | Title | Date |
| /s/ MARTINE ROTHBLATT | Chairperson, Chief Executive Officer, and Director(Principal Executive Officer) | February 25, 2026 |
| Martine Rothblatt | ||
| /s/ JAMES C. EDGEMOND | Chief Financial Officer and Treasurer(Principal Financial Officer and Principal Accounting Officer) | February 25, 2026 |
| James C. Edgemond | ||
| /s/ CHRISTOPHER CAUSEY | Director | February 25, 2026 |
| Christopher Causey | ||
| /s/ RAYMOND DWEK | Director | February 25, 2026 |
| Raymond Dwek | ||
| /s/ RICHARD GILTNER | Director | February 25, 2026 |
| Richard Giltner | ||
| /s/ RAYMOND KURZWEIL | Director | February 25, 2026 |
| Raymond Kurzweil | ||
| /s/ JAN MALCOLM | Director | February 25, 2026 |
| Jan Malcolm | ||
| /s/ LINDA MAXWELL | Director | February 25, 2026 |
| Linda Maxwell | ||
| /s/ NILDA MESA | Director | February 25, 2026 |
| Nilda Mesa | ||
| /s/ JUDY D. OLIAN | Director | February 25, 2026 |
| Judy D. Olian | ||
| /s/ CHRISTOPHER PATUSKY | Director | February 25, 2026 |
| Christopher Patusky | ||
| /s/ LOUIS W. SULLIVAN | Director | February 25, 2026 |
| Louis W. Sullivan | ||
| /s/ TOMMY G. THOMPSON | Director | February 25, 2026 |
| Tommy Thompson | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.